Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry

NCT04085029 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04085029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04085029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Lead sponsor
Duke University
Phase
Observational
Overall status
Recruiting
Start date
September 26, 2019
Completion date
September 30, 2029
Enrollment
300 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, oligometastasis